Top news from MedWatch this week
Monday
Drug commercialization company Medical Knowledge Group acquired by Novo Holdings
EQT reinforces long-term nature of WS Audiology investment
Ascendis Pharma extends trial of growth hormone in adults
Tuesday
”Bad luck” delayed Leo Pharma’s prize candidate for eight months
Novo Holdings acquires US contract manufacturer in second billion-dollar deal in two days
WS Audiology acquires Brazilian distributor
Former Lundbeck venture advisors start new biotech fund
Wednesday
Genmab buys ADC technology license from Synaffix
Thursday
Novo Nordisk trains sights on Roche with ”aggressive” hemophilia drug development
FDA approves Lundbeck’s schizophrenia treatment for teenagers
Novo Nordisk expects lack of Wegovy doses to continue until H2 2022
Novo Nordisk expands research collaboration to develop hemophilia drug
Former Alnylam CEO appointed new chair of Hemab
Set-in-stone criteria will reduce risk for new biotech fund
Pharmacosmos investigates anemia treatment in new patient group
Friday
Amgen combines Danish and Norwegian units
Children’s pain relief company wants former Genmab boss on board
